Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Saline, Triamcinolone with lidocaine, Lidocaine.
- Who it may be relevant to
- Registry conditions: TMJ Pain. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Clinical Assessment of The Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial
Overview
This study aims to clinically evaluate the efficacy of trigger points using active drug mix (Triamcinolone with lidocaine) on relief of myofascial pain of jaw muscle.
Interventions
- Drug Saline
Patients will take 1 ml of lidocaine 2% - Drug Triamcinolone with lidocaine
Patients will take 1 ml of active drug mix (1/4 ml of Triamcinolone and 3/4 ml of lidocaine) - Drug Lidocaine
Patients will take 1 ml lidocaine 2%
Primary outcome measures
- current pain intensity [Time frame: 1 week , 1 month , 3 months after treatment]
Secondary outcome measures (4)
- maximum mouth opening [Time frame: 1 week , 1 month , 3 months after treatment]
- post operative demands for analgesics [Time frame: 1 week , 1 month , 3 months after treatment]
- patient satisfaction [Time frame: 1 week , 1 month , 3 months after treatment]
- pressure pain threshold (PPT) [Time frame: 1 week , 1 month , 3 months after treatment]
Eligibility criteria
Inclusion criteria
- Age more than or equal 18 years
- Both sexes
- Patients' willingness to follow instructions
Exclusion criteria
- Patients who will be using any medications to reduce the pain and/or have any effect on the skeletal muscle
- Clinical conditions such as pregnancy
- Medical problems that may interfere with the procedures such as bleeding disorders
- Cognitive impairment or exhibited inadequate cooperation
- Patients will be receiving physical therapy or wearing occlusal splint in the same period of the research
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07445191 · injection of masseter muscle